Cold Spring Harbor Laboratory and North Shore-LIJ to Form $120 Million Collaboration

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Bruce Stillman, president and CEO of CSHL, and Michael J. Dowling, president and CEO of the North Shore-LIJ Health System

Two New York institutions—Cold Spring Harbor Laboratory and the North Shore-LIJ Health System—announced a $120 million cancer research collaboration on April 2.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login